Author

S. M. Lima

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

J. M. Irish· 2 shared A. K. von Lersner· 1 shared A. M. Mistry· 1 shared A. Weaver· 1 shared A. Zijlstra· 1 shared B. C. Mobley· 1 shared B. H. Sung· 1 shared C. E. Roe· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

J. M. Irish

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

EV Fingerprinting: Resolving extracellular vesicle heterogeneity using multi-parametric flow cytometry

A. K. von Lersner, F. C. L. Fernandes, P. M. M. Ozawa, T. Vagner, S. M. Lima, B. H. Sung, M. Wehbe, K. Franze, J. T. Wilson, J. M. Irish, A. Weaver, D. Di Vizio, A. Zijlstra

EV Fingerprinting uses flow cytometry to resolve EV heterogeneity and detect tumor-derived EVs in plasma.

bioRxiv · Nov 10, 2022 · PreprintCell Biology

Immune cell regulation in stem cell niche contacting glioblastomas.

T. Bartkowiak, S. M. Lima, M. J. Hayes, A. M. Mistry, J. Sinnaeve, N. Leelatian, C. E. Roe, B. C. Mobley, K. D. Weaver, R. C. Thompson, L. B. Chambless, R. A. Ihrie, J. M. Irish

This study shows that glioblastomas contacting the lateral ventricle have distinct immune features, including elevated T cell checkpoint receptors and suppressive myeloid cells, suggesting new therapeutic targets.

bioRxiv · Feb 16, 2022 · PreprintImmunology